Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03235180 · ClinicalTrials.gov registry record · Phase 4
Ultrasound Evaluation of Crohn's Disease
A Phase 4 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT03235180: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.
NCT03235180 is a Phase 4 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03235180, a Phase 4 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.
Interventions
- DRUG Sulfur Hexafluoride
- DEVICE Ultrasound Elastography
- DEVICE Ultrasound Vascularity
- DEVICE Magnetic Resonance Enterography (MRE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2021-10-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03235180
The ClinicalTrials.gov registry entry for NCT03235180 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sulfur Hexafluoride is the first listed.
NCT03235180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03235180 about?
NCT03235180 is a clinical study titled "Ultrasound Evaluation of Crohn's Disease". The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.
What is the current status of trial NCT03235180?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2017-06-16. Estimated completion is 2021-10-12.
What interventions are being tested in trial NCT03235180?
The interventions under investigation include: Sulfur Hexafluoride (DRUG), Ultrasound Elastography (DEVICE), Ultrasound Vascularity (DEVICE), Magnetic Resonance Enterography (MRE) (DEVICE).
Who is sponsoring clinical trial NCT03235180?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.